EHS
EHS

Top stories in hematology/oncology: Deadly subtype makes up 17% of metastatic prostate cancer, American Cancer Society creates blueprint to reduce cancer mortality

Among the top stories in hematology/oncology is study data showing a particularly deadly subtype of prostate cancer occurs in 17% of metastatic, castration-resistant prostate cancer. Researchers from the American Cancer Society identified trends in disparities and outcomes for cancer over several decades to stress the need for better care. Other top stories include a $20 million grant received by the Henry Ford Cancer Institute to fund the creation of a new multi-institutional pancreatic cancer research consortium, clonal hematopoiesis-related mutation appeared to be misinterpreted as
EHS
Back to top button